Combination therapy of ARS using post-irradiation administration of G-CSF and synthokine SC-55494 (a synthetic high-affinity IL-3 ligand [58]) has been reported to be effective against post-irradiation neutropenia and thrombocytopenia in rhesus monkeys [59]. This evidence concerns the gene CSF3 and Axenfeld-Rieger syndrome.